595 related articles for article (PubMed ID: 20522774)
1. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.
Bloom JD; Gong LI; Baltimore D
Science; 2010 Jun; 328(5983):1272-5. PubMed ID: 20522774
[TBL] [Abstract][Full Text] [Related]
2. Virology. Helping the resistance.
Holmes EC
Science; 2010 Jun; 328(5983):1243-4. PubMed ID: 20522766
[No Abstract] [Full Text] [Related]
3. A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.
Bloom JD; Nayak JS; Baltimore D
PLoS One; 2011; 6(7):e22201. PubMed ID: 21799795
[TBL] [Abstract][Full Text] [Related]
4. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
Behera AK; Basu S; Cherian SS
Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
[TBL] [Abstract][Full Text] [Related]
6. [Oseltamivir resistance depends on the position 273 amino acid of neuraminidase of the type A influenza virus (H1N1), circulating in human population].
Riabinin VA; Kostina EV; Siniakov AN
Bioorg Khim; 2011; 37(5):711-4. PubMed ID: 22332369
[TBL] [Abstract][Full Text] [Related]
7. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
8. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.
McKimm-Breschkin JL
Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894
[TBL] [Abstract][Full Text] [Related]
9. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
Butler J; Hooper KA; Petrie S; Lee R; Maurer-Stroh S; Reh L; Guarnaccia T; Baas C; Xue L; Vitesnik S; Leang SK; McVernon J; Kelso A; Barr IG; McCaw JM; Bloom JD; Hurt AC
PLoS Pathog; 2014 Apr; 10(4):e1004065. PubMed ID: 24699865
[TBL] [Abstract][Full Text] [Related]
10. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
Abed Y; Pizzorno A; Bouhy X; Boivin G
Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
[TBL] [Abstract][Full Text] [Related]
11. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
12. [Molecular genetic studies of the susceptibility of epidemic influenza A(H1N1) virus strains isolated in the 2006-2009 seasons in Russia to oseltamivir (Tamiflu)].
Beliakova NV; Al'khovskiĭ SV; Shevchenko ES; Prilipov AG; Abramov DD; Kolobukhina LV; Merkulova LN; Trushakova SV; Burtseva EI
Vopr Virusol; 2010; 55(5):10-3. PubMed ID: 21260988
[TBL] [Abstract][Full Text] [Related]
13. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.
Ginting TE; Shinya K; Kyan Y; Makino A; Matsumoto N; Kaneda S; Kawaoka Y
J Virol; 2012 Jan; 86(1):121-7. PubMed ID: 22013054
[TBL] [Abstract][Full Text] [Related]
14. Genetic sequencing of influenza A (H1N1) pdm09 isolates from South India, collected between 2011 and 2015 to detect mutations affecting virulence and resistance to oseltamivir.
Nandhini P; Sistla S
Indian J Med Microbiol; 2020; 38(3 & 4):324-337. PubMed ID: 33154243
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.
Kannan S; Kolandaivel P
J Biomol Struct Dyn; 2018 Dec; 36(16):4255-4269. PubMed ID: 29199545
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
Enserink M
Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
[No Abstract] [Full Text] [Related]
17. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
[TBL] [Abstract][Full Text] [Related]
18. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
[TBL] [Abstract][Full Text] [Related]
19. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro.
Renzette N; Caffrey DR; Zeldovich KB; Liu P; Gallagher GR; Aiello D; Porter AJ; Kurt-Jones EA; Bolon DN; Poh YP; Jensen JD; Schiffer CA; Kowalik TF; Finberg RW; Wang JP
J Virol; 2014 Jan; 88(1):272-81. PubMed ID: 24155392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
